New Molecules Derived from CBD can be sued to treat Skin Diseases
Share
An international research team created new compounds to suppress the BACH1 protein and activate the NRF2 protein. This protein regulates the expression of particular genes. These particular genes, including HMOX1, which encodes for heme oxygenase 1, as well as numerous others that operate autonomously of BACH1, defend cells against oxidative stress.
The newly created particles, which are obtained from cannabinoids, use double antioxidant capacity: on the one hand, they prevent BACH1 and thereby induce heme oxidase 1 expression; but at the other hand, they stimulate NRF2, which also initiates the expression of heme oxygenase 1 as well as other oxidative genes.
For the treatment of skin conditions like neurodermatitis and epidermolysis bullosa, a relatively rare condition about which little study is conducted, this mode of action is particularly intriguing. Additionally, this molecule has fantastic potential for use in cosmetic products due to its antioxidant properties. Read more about the research paper - https://scitechdaily.com/new-molecules-derived-from-cbd-designed-with-more-potent-antioxidants-for-treating-skin-diseases/.